Research has confirmed that the key targets of Galangin against liver cancer were SRC, ESR1, MMP9, CDK4, CCNB1, MMP2, CDK2, CDK1, CHEK1 and PLK1 (Li et al., 2024). Here, SRC is linked to liver cancer.